Altraz Tablet contains Anastrozole, a nonsteroidal aromatase inhibitor. It is used primarily in treating hormone receptor-positive breast cancer in postmenopausal women. By reducing estrogen levels, Altraz slows or stops the growth of estrogen-dependent cancer cells. It is often prescribed alongside surgery or radiation therapy to improve treatment outcomes (Mayo Clinic, Drugs.com).

Key Benefits & Uses

Altraz Tablet offers several advantages for patients:

• Effective in Early-Stage Breast Cancer: It can be used alone or with other therapies to manage early breast cancer (FDA).

• First-Line Treatment for Advanced Cases: It serves as initial therapy for advanced breast cancer that has spread within the breast or other body parts (WebMD).

• Hormone Receptor-Positive Tumors: It specifically targets tumors that rely on estrogen, maximizing effectiveness (PubMed).

In addition, its well-established safety profile makes it a preferred choice for long-term therapy.

How to Use

Take Altraz Tablet exactly as prescribed by your healthcare provider. Typically, the dosage is 1 mg once daily, with or without food. Swallow the tablet whole with water and avoid crushing or chewing it. Moreover, taking it at the same time each day helps maintain consistent medication levels (Healthline).

Important Safety Information

• Not for Premenopausal Women: Only postmenopausal women should use this medication.

• Pregnancy and Breastfeeding: Avoid use during pregnancy or breastfeeding due to potential risks.

• Liver and Kidney Conditions: Dose adjustments may be necessary for patients with liver or kidney issues.

• Allergic Reactions: Seek immediate medical help for symptoms like rash, swelling, or difficulty breathing (WHO).

Common Side Effects

Some patients may experience:

• Hot flashes

• Nausea

• Osteoporosis (bone thinning)

• Skin rash

• Weakness

Most side effects are mild and tend to improve over time. However, consult your doctor if they persist or worsen (Drugs.com).

Why Choose Altraz Tablet

Altraz Tablet provides a targeted approach for managing hormone receptor-positive breast cancer. Its aromatase inhibitor mechanism effectively reduces estrogen levels, inhibiting cancer cell growth. Furthermore, the convenient once-daily dosage and reliable safety profile make it an excellent option for long-term therapy (Mayo Clinic, FDA).